AVAC analysis
Continued analysis of PEPFAR data released by the US Department of State last week points to a much more nuanced and complicated narrative about the state of the HIV response. A Vox Future Perfect piece dissects the latest figures, covering July–September 2025, which the administration presents as a picture of continuity and efficiency: treatment numbers appear stable, and prevention among pregnant and breastfeeding women appear to make a targeted gain. But the article, alongside independent analyses by KFF, amfAR’s Brian Honerman and co-authors, Jirair Ratevosian, and AVAC, makes clear that this snapshot obscures deeper disruptions. Critical gaps in testing, prevention and workforce capacity are minimized, or left out entirely, to create a distorted picture of a resilient program.
The Vox analysis also calls out the absence of a full year of data. While the Department of State cited reporting and implementation challenges, previous datasets that were posted then subsequently removed in January 2026, tell a different story. Analyses by amfAR and the International AIDS Society of those unreleased figures reveal far sharper disruptions across testing, prevention and service delivery, particularly in the wake of the January 2025 foreign aid freeze. Taken together, the evidence suggests that the final quarter may represent the most stable period of an otherwise deeply destabilizing year — masking the scale and severity of the broader setbacks that may inevitably emerge farther down the road.
IMPLICATIONS: Incomplete or selectively framed data can shape policymaker perceptions, donor decisions and country-level planning, which could potentially justify further cuts or an urgent need to surge resources to counteract devastating actions stemming from the foreign aid freeze and stop work orders. And as Vox reports, “For years, one of PEPFAR’s strengths was its system that generated unusually granular public data about where the program was functioning well and where it wasn’t. That made it possible to spot problems and course-correct, part of what made PEPFAR so successful and helped save more than 25 million lives. Now that picture is much thinner… And it is unclear whether this kind of detailed HIV-specific reporting will continue at all under the terms of its America First Global Health Strategy.”
Further coverage:
AVAC publishes a weekly Global Health Watch, a curated digest of key developments in global health. Access this week’s issue (#66, 1 May) here.
Source : AVAC
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.